Skip to main content

RCC GPE C27 (Guaifenesin and Phenylephrine Hydrochloride 400 mg / 10 mg)

Pill with imprint RCC GPE C27 is White, Elliptical/Oval and has been identified as Guaifenesin and Phenylephrine Hydrochloride 400 mg / 10 mg. It is supplied by Reese Pharmaceutical Co.

Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 400 mg / 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RCC GPE C27

Guaifenesin and Phenylephrine Hydrochloride

Imprint
RCC GPE C27
Strength
400 mg / 10 mg
Color
White
Shape
Elliptical/Oval
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Reese Pharmaceutical Co.
National Drug Code (NDC)
37012-0077
Inactive Ingredients
croscarmellose sodium, lactose, maltodextrin, microcrystalline cellulose, mineral oil, povidone, magnesium silicate, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.